One of the most serious chronic complications of diabetes is diabetic foot infections. Neuropathy, peripheral vascular disease and trauma are among the leading factors to development of diabetic foot ulcers and predispose to progress the diseases to diabetic foot infections. Delay of diagnosis and treatment and poor antibiotic treatment of diabetic foot infections can result in amputation. Diabetic foot ulcers and infections are the main causes of foot amputation around the world. The five-year survival rate of patients underwent foot amputation due to diabetic foot infections is low. With this review it's aimed to give information about the current epidemiology, risk factors, diagnosis and antimicrobial therapy of diabetic foot infections. In addition it's intended to give the results of Dermobor treatment in small number of cases with diabetic foot ulcers and infections.
INTRODUCTION
Diabetes mellitus (DM) remains one of the major public health problems worldwide. The prevalence of both type 1 and 2 DM is increasing. Type 2 DM is responsible for almost 90% of diabetes patients. Obesity, inactivity, family history, age, gestation, high blood pressure, abnormal cholesterol and triglyceride levels and polycystic ovary syndrome play crucial role to get type 2 DM (1) . The number of people living with diabetes is growing fast. In 2013 the number of patients with type 2 DM was 382 million. With this speed, it's estimated that, there will be 592 million people by 2035 (2) . Turkey has the highest rate of prevalence among the European countries with 13.7% although the global prevalence is 8.5% (3) . Diabetes is considered one of the devastating diseases with high mortality rate. In 2015, of the 56.4 million deaths worldwide, 1.6 million were due to DM. It remains the 7 th leading cause of death. Diabetes is also very costly both for the individual and for the health systems of the countries. In 2013, the cost for diabetes and related diseases reached $ 548 billion all over the world (4) .
Diabetic foot infections (DFIs) are one of the most serious chronic complications of DM. Diabetic foot ulcers complicate the disease. They occur more than 15% of diabetic patients during their lifetime (5, 6) . Treatment of diabetic foot ulcers (DFUs) and subsequent infections is difficult. Multidisciplinary approach is needed for the management of DFUs and DFIs. The most dramatic end result of DFUs and DFIs are foot amputation. The number has been reaching one in every 30 second in the world. The annual number of patient, undergoing foot amputation is around 12,000 in Turkey, and mostly due to DFIs (7) (8) (9) .
The aim of this review is to review the current empiric and definitive antimicrobial therapy and to discuss the effectiveness of Dermobor gel (Genbor Biyosidal Yaşam Ürünleri San.Tic.Ltd.Şti, İstanbul, Turkey) in the treatment of DFUs and DFIs. It's believed that this review may be useful to primary care physicians, infectious diseases physicians, vascular surgeons, orthopedics, nurses and podiatrists.
RISK FACTORS AND PATHOGENESIS OF DIABETIC FOOT INFECTIONS
Most diabetic foot infections begin with a wound and once an infection occurs, the risk of amputation increases significantly. The prevalence of DFUs are around 4-10% depending on age and duration of DM. The lifetime prevalence reaches 15%. Most of the DFUs (60-80%) heal, while 10-15% of them remain unhealed. The healing of DFUs also depend on the characteristics of the wounds. For example neuropathic wounds are more likely to heal over a period of 4-5 months while neuro-ischemic ulcers take longer period and generally result in amputation. Indeed 10-30% of patients with DFUs progress to amputation within a period of 6-18 months after the first evaluation. Among amputated patients five years mortality is around 50-60% (10, 11) .
Multiple risk factors can play a role in the occurrence of DFUs such as; neuropathy, peripheral vascular disease, traumas, poor glycemic control and cigarette smoking. Among these neuropathy and peripheral vascular diseases are the most important factors. Sensory neuropathy can allow diminished perception of pain, pressure and heat, thus patients cannot distinguish well an injury or temperature to their feet. Motor neuropathy can cause foot deformities by muscle weakness, atrophy and paresis, which it becomes open pressure-induced soft tissue damage. In addition, autonomic neuropathy causes dry cracked skin by diminishing sweat secretion, resulting in a disruption of skin integrity. The deficiency of blood flow due to peripheral arterial diseases can results in the development of the wound and gangrene. In this setting the entry of microorganisms into the deep skin structures and the development of microbial infection become easy (12, 13) .
CLASSIFICATION OF DIABETIC FOOT ULCERS
Diabetic foot ulcers generally classified as neuropathic, ischemic or both. Neuropathic DFUs is characterized with the presence of peripheral neuropathy without ischemia while ischemic DFUs is defined with the existence of symptoms related to peripheral artery disease with no peripheral neuropathy. In neuro-ischemic DFUs neuropathy and ischemia coexist (14) . In describing the extent and the severity of lesions classification of DFUs is important. There are various classification schemes including; Wagner-Meggitt, PEDIS classification, Kings College Hospital classifications, and University of Texas classification. The Wagner-Meggitt and University of Texas are the most well accepted systems ( Table 1) . The most common possible causative mi-crorganisms responsible from DFIs are; Staphylococcus aureus, Staphylococcus agalactiae, coagulase negative staphylococcus (CNS), Streptococcus pyogenes, Escherichia coli, Klebsiella pneumoniae, Proteus spp., Enterobacter spp., Enterococcus spp., Pseudomonas aeruginosa and Acinetobacter baumannii.
CLINICAL SIGNS OF DIABETIC FOOT INFECTIONS
Diabetic foot infections are often accompanied by the cardinal manifestations of inflammation such as; erythema, warmth, swelling, tenderness and presence of pus in an ulcer or sinus tract. But, these signs may not be evident in all cases, especially in the presence of severe ischemia. Patients with sensory neuropathy may have diminished sensation in the involved area and may not complain of tenderness, even in the setting of infection. In such patients, infection may progress to involve deeper tissues (15) . Presence of gangrene, severe ischemia, or tissue necrosis may remind the existence of a limb threatening infection. Systemic signs such as fever, chills, hypotension, and tachycardia may accompany local signs of infection and indicate an increased severity of infection, like sepsis and septic shock. Osteomyelitis can occur in the setting of a diabetic foot wound with or without evidence of local soft tissue infection. It should be diagnosed and aggressively treated as soon as possible.
DIAGNOSIS OF DIABETIC FOOT INFECTIONS
The diagnosis of DFIs depends on the presence of two or more cardinal manifestations of inflammation such as; erythema, warmth, tenderness, swelling and induration or the presence of pus (15) . For definitive diagnosis the growth of the microorganism in culture DFIs is essential. In the absence of clinical signs and symptoms the growth of the microorganism should be assessed with caution. This situation is generally due to sample taken by superficial swabs. This method is not reliable for predicting the definitive pathogens. For the accurate diagnosis samples for culture should be aspirated from an abscess or curettage from the ulcer base following superficial debride- (15, 16) . Definitive diagnosis of osteomyelitis generally depends on isolation of bacteria from a sterilely obtained bone biopsy sample with histologic evidence. But bone biopsy is not always routinely available or practical. In such instances, the presumptive diagnosis is based on clinical and radiological assessment. The following factors increase the likelihood of osteomyelitis; grossly visible bone or ability to probe to bone, ulcer size larger than 2 cm 2 , ulcer duration longer than one to two weeks, and erythrocyte sedimentation rate (ESR) >70 mm/h. On the presence of one or more findings the suitable changes in conventional radiograph can be helpful in making the diagnosis of osteomyelitis. Magnetic resonance imaging (MRI) is highly sensitive and specific for the diagnosis of osteomyelitis. If bone is grossly visible, radiographic examination is not necessary (17) .
ANTIMICROBIAL TREATMENT OF DIABETIC FOOT INFECTIONS
For the success of the treatment of DFIs, multidisciplinary approach plays a key role. Management of DFIs requires attentive wound care, glycemic control, good nutrition, supply of fluid and electrolyte balance and appropriate antimicrobial therapy (18, 19) . Patients with ulcerations that are not infected should not receive antibiotic therapy. In this situation local wound care and reducing the pressure on the foot is adequate. The selection of empiric antibiotic therapy should be considered based on the severity of infection and the likelihood of involvement of resistant organisms. If it is needed empiric therapy can be changed to definitive antibiotic treatment depending on culture and susceptibility results. aeruginosa, and anaerobes should be covered by empiric antibiotic therapy (15, 20, 21) . In patients with life threatened DFIs, long term chronic wound, prior antibiotic use, and exudative wounds, P. aeruginosa should be considered and covered in empiric antibiotic therapy (22) . The choice of empiric antibiotic therapy is summarized in Table 2 .
EMPIRIC ANTIBIOTIC THERAPY OF DIABETIC FOOT INFECTIONS

DURATION OF ANTIMICROBIAL THERAPY
Patients with mild infection oral antibiotic therapy should be given for about one to two weeks. Antibiotics do not need to be given until wound closure. Patients with moderate or severe infection, requiring surgical debridement, intravenous antibiotic therapy is usually adequate for two to four weeks without osteomyelitis. If there is a good response to parenteral therapy, oral agents can be used to complete the course of treatment. In patients with osteomyelitis, surgical resection is generally beneficial. In same studies it is demonstrated that antibiotic therapy for longer period without resection succeed the healing about 60 to 90%, which is comparable to those reported with surgery. The optimal duration is uncertain. But four to six weeks is an appropriate course if there is residual infected bone following debridement of necrotic bone. However, if necrotic bone remains, clinical cure may require several months with antibiotic therapy (15, 20) . tions and wound culture results positives were used oral antibiotics also. All of the patients received Dermobor gel two times a day. Dermobor gel pomaded around and into the wounds' areas. Granulation tissue formation > 75%, were seen in six patients in 4-5 weeks, wound closure has occurred in two patients in 6-7 weeks. The treatment has been continuing in remaining four patients.
In the first picture complete closure in the DFI was seen at the end of 50 th days of Dermobor gel, twice a day, in a 57 years old male patient with DFI. In the second picture 75% granulation tissue formation was occurred at the 16 th days of Der-mobor gel treatment in a 72 years old female patient with DFI ( Figure 1 and Figure 2 ).
CONCLUSION
Diabetic foot ulcers and infections are the one of the most hopeless chronic complications for diabetic patients since the healing of the wounds and infections generally take longtime. On the other hand sometimes the efforts of treatment cannot be resulted in success and can progress to the need of amputation. But currently it is believed that most of the DFUs and DFIs can be managed and the foot amputation can be prevented with careful patient management. According to the 33 Cyprus J Med Sci 2017; 2: 29-34 Büke Ç. Current Treatment of Diabetic Foot Infections results of the small number of cases with Dermobor in DFIs, it's seen that Dermobor is seen one of the hopeful choice in DFIs. It acts as both antibacterial and formation of granulation tissue. But for the assessment of the effect of Dermobor, multicentric studies are needed.
